Hudson Bay Capital Management LP Onconova Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.46 - $2.82 $132,746 - $256,400
-90,922 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.49 - $3.73 $186,157 - $278,862
-74,762 Reduced 45.12%
90,922 $232,000
Q3 2021

Nov 15, 2021
BUY
$3.81 - $6.76 $631,256 - $1.12 Million
165,684 New
165,684 $635,000

Others Institutions Holding ONTX

# of Institutions
4
Shares Held
276K
Call Options Held
0
Put Options Held
0
View Full List

About Onconova Therapeutics, Inc.

ONTX Quotes by TradingView
  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email